Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays.

× No keyword cloud information.

8 in total

1. Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation.

Authors: Masahiro Ieko; Mika Yoshida; Sumiyoshi Naito; Toru Nakabayashi; Kaoru Kanazawa; Kazuhiro Mizukami; Masaya Mukai; Tatsuya Atsumi; Takao Koike
Journal: Int J Hematol Date: 2010-05-21 Impact factor: 2.490

2. Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men.

Authors: Mirjam E Meltzer; Carine J M Doggen; Philip G de Groot; Joost C M Meijers; Frits R Rosendaal; Ton Lisman
Journal: Haematologica Date: 2009-04-18 Impact factor: 9.941

Review 3. Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?

Authors: Karen Claesen; Joachim C Mertens; Dorien Leenaerts; Dirk Hendriks
Journal: Int J Mol Sci Date: 2021-01-17 Impact factor: 5.923

Review 4. Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review.

Authors: Machteld Sillen; Paul J Declerck
Journal: Int J Mol Sci Date: 2021-04-01 Impact factor: 5.923

5. A Case-Control Study of the Dose-Response Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Acute Myocardial Infarction.

Authors: Mengnan Zhao; Dan Zhao; Yuning Li; Xiaonan Wang; Boyu Yi; Bo Zhou
Journal: Front Cardiovasc Med Date: 2022-02-28

6. Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease.

Authors: Maciej Bochenek; Jaroslaw Zalewski; Jerzy Sadowski; Anetta Undas
Journal: J Thromb Thrombolysis Date: 2013-02 Impact factor: 2.300

7. Association between polymorphisms in the flanking region of the TAFI gene and atherosclerotic cerebral infarction in a Chinese population.

Authors: You Li; Zhiliang Zeng; Jianghao Zhao; Guoda Ma; Lili Cui; Hua Tao; Zhijun Lin; Yanyan Chen; Bin Zhao; Yusen Chen; Keshen Li
Journal: Lipids Health Dis Date: 2014-05-13 Impact factor: 3.876

8. A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.

Authors: Tara M Stanne; Maja Olsson; Erik Lorentzen; Annie Pedersen; Anders Gummesson; Ann Gils; Katarina Jood; Gunnar Engström; Olle Melander; Paul J Declerck; Christina Jern
Journal: Thromb Haemost Date: 2018-01-29 Impact factor: 5.249

8 in total